Investegate announcements from Karolinska Development AB (pub, Karolinska Development’s portfolio company Promimic presents preclinical results showing decreased bacterial adhesion to implants
Investegate announcements from Karolinska Development AB (pub, Karolinska Development’s portfolio company Biosergen prepares Phase 2 study in mucormycosis infected patients
Investegate announcements from Karolinska Development AB (pub, Karolinska Development s portfolio company AnaCardio raises SEK 33 million to progress clinical development of a novel therapy for heart failure
Investegate announcements from Karolinska Development AB (pub, Karolinska Development’s portfolio company Modus Therapeutics initiates Phase 1b trial of its drug candidate sevuparin